**Core Concept**
The management of hyperthyroidism in pregnancy requires careful selection of antithyroid medications due to their potential effects on the fetus. The ideal antithyroid drug should have a strong efficacy, minimal side effects, and a favorable fetal safety profile.

**Why the Correct Answer is Right**
Propylthiouracil (PTU) is the preferred antithyroid medication in the first trimester of pregnancy due to its lower risk of hepatotoxicity compared to methimazole. PTU inhibits thyroid hormone synthesis by blocking the peripheral conversion of T4 to T3 and the synthesis of thyroid hormones. It also has a rapid onset of action, making it an effective choice for managing hyperthyroidism in pregnant women. PTU is excreted in breast milk, but its effects on the infant are minimal.

**Why Each Wrong Option is Incorrect**
**Option A:** Methimazole is associated with a higher risk of hepatotoxicity and is therefore generally avoided in the first trimester of pregnancy.
**Option B:** Carbimazole is a prodrug that is converted to methimazole in the body, making it a less favorable choice in pregnancy due to the associated risks.
**Option C:** Iodine is not an effective treatment for hyperthyroidism and can actually worsen the condition by stimulating the release of thyroid hormones.

**Clinical Pearl / High-Yield Fact**
In pregnant women with hyperthyroidism, it is essential to monitor thyroid function tests closely and adjust the antithyroid medication dose as needed to maintain euthyroidism. This helps to prevent complications such as preterm birth, low birth weight, and fetal thyroid dysfunction.

**Correct Answer:** A. Propylthiouracil